ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML

Open Access

Peer-reviewed

Research Article

Marta E. Capala,

Affiliation Department of Experimental Hematology, Cancer Research Center Groningen (CRCG), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
⨯
Edo Vellenga,

Affiliation Department of Experimental Hematology, Cancer Research Center Groningen (CRCG), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
⨯
Jan Jacob Schuringa

* E-mail: j.j.schuringa@umcg.nl

Affiliation Department of Experimental Hematology, Cancer Research Center Groningen (CRCG), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
⨯

Reader Comments (0)

Acute myeloid leukemia
Is the Subject Area "Acute myeloid leukemia" applicable to this article?

Thanks for your feedback.
Leukemia
Is the Subject Area "Leukemia" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Cell differentiation
Is the Subject Area "Cell differentiation" applicable to this article?

Thanks for your feedback.
Stem cells
Is the Subject Area "Stem cells" applicable to this article?

Thanks for your feedback.
Hematopoietic stem cells
Is the Subject Area "Hematopoietic stem cells" applicable to this article?

Thanks for your feedback.
Karyotypes
Is the Subject Area "Karyotypes" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.